Company profile
Avai Bio, Inc.
OTC: AVAI · Technology · Software - Application
PublicHQ Vilnius, NVCIK 0001740797Reports USD
#924 of 1,169 Technology companies by revenue
EA Score
17DFH 16DQ 15GM —SS 26
v0.1 · 55/100 weight · provisional
↑ market scale, filing timeliness · ↓ workforce scale, disclosure history
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$1.7M
Employees
1
as of 2026-07-19
Market cap
$18.3M
as of 2026-07-19
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$276.3k$276.3k2024
Net income-$1.7M-$1.7M2026
Operating income-$1.7M-$1.7M2026
Total assets$572.7k$572.7k2026
Liabilities$3.4M$3.4M2026
Equity-$2.8M-$2.8M2026
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Avai Bio, Inc.’s revenue?
Avai Bio, Inc. booked $276.3k in FY2024 revenue — among the slowest-growing Technology companies we track, at a -633.1% net margin.
Peers · Technology
GivBux, Inc.21DBrandPilot AI Inc——Hubb Ventures Inc.——Brand Engagement Network, Inc.24Di3 Interactive Inc.——Everything Blockchain, Inc.——Key facts
CEOChris Winter
SectorTechnology
IndustrySoftware - Application
HeadquartersVilnius, NV
ExchangeOTC: AVAI
Employees1
IPO date2020-04-06
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.